Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fractional CO2 laser-assisted delivery of topical articaine + epinephrine vs. topical EMLA
2014-001988-12Phase 4Active
- Sponsor
- Amsterdam University Medical Center
- Start
- Sep 2014
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of articaine, epinephrine, lidocaine and prilocaine in acne scar and residual scarring (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Pain VAS score immediately after fractional laser treatment. Started Sep 2014; status: active.
02
Drugs
articaineepinephrinelidocaineprilocaine
03
Conditions
acne scarresidual scarring
Beyond the preview
Go deeper on 2014-001988-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001988-12.